Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors

Author:

Bertucci François12,Boudin Laurys1ORCID,Finetti Pascal1,Van Berckelaer Christophe3,Van Dam Peter3,Dirix Luc45,Viens Patrice2,Gonçalves Anthony12,Ueno Naoto T.6,Van Laere Steven34,Birnbaum Daniel1,Mamessier Emilie1

Affiliation:

1. Predictive Oncology Laboratory, “Equipe Labellisée Ligue Contre Le Cancer”, Centre De Recherche En Cancérologie De Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille Université, Marseille, France

2. Department of Medical Oncology, CRCM, Institut Paoli-Calmettes, Marseille, France

3. Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp Belgium

4. Translational Cancer Research Unit, GZA Hospitals & CORE, MIPRO, University of Antwerp, Antwerp, Belgium

5. Department of Oncological Research, Oncology Center, GZA Hospitals Sint-Augustinus, Antwerp, Belgium

6. Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3